Ohcanbohtosat - Cheng E. Chee

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors Dahkki Ruth Plummer, Mikael H. Sodergren, Rose Hodgson, Bríd M. Ryan, Nina Raulf, Joanna P. Nicholls, Vikash Reebye, Jon Voutila, Laura Sinigaglia, Tim Meyer, David J. Pinato, Debashis Sarker, Bristi Basu, Sarah Blagden, Natalie Cook, Thomas R. Jeffrey Evans, Jeffrey Yachnin, Cheng E. Chee, Daneng Li, Anthony El-Khoueiry, Maria Diab, Kai-Wen Huang, Madhava Pai, Duncan Spalding, Thomas Talbot, Marcus S. Noel, Bridget Keenan, Devalingam Mahalingam, Min-Sun Song, Mélanie Grosso, Denis Arnaud, Aurelie Auguste, Dimitris Zacharoulis, Jan Storkholm, Iain McNeish, Robert Habib, John J. Rossi, Nagy A. Habib

Viečča ollesdeavstta